Endomysial Antibody Igg

• Principle: The Endomysial Antibody IgG Test is based on immunofluorescence assay (IFA) technology, detecting IgG antibodies targeting endomysium, a connective tissue component found in the gut
• Target Antigen: The test specifically targets IgG antibodies directed against endomysium, aiding in the diagnosis of autoimmune responses related to gluten sensitivity or celiac disease
• Methodology: The assay involves incubating patient serum with tissue sections containing endomysial antigens, followed by detection using fluorescent-labelled antibodies, allowing visualization under a fluorescence microscope
• Sensitivity and Specificity: The test is known for its high sensitivity and specificity, contributing to the accurate identification of endomysial antibodies

• Celiac Disease Diagnosis: The primary use is in the diagnosis of celiac disease, especially in individuals with IgA deficiency, as IgG antibodies are an alternative marker
• Monitoring Gluten-Free Diet Compliance: The test helps assess adherence to a gluten-free diet in individuals with known gluten sensitivity
• Identification of Gluten-Related Disorders: It aids in identifying gluten-related autoimmune conditions beyond celiac disease

• IgG Antibody Detection: The test includes the detection and measurement of IgG antibodies against endomysium, providing quantitative information
• Tissue Substrate: The assay employs tissue sections with endomysial components as a substrate for antibody binding
• Fluorescent Labeling: Fluorescent-labeled antibodies are used to visualize the binding of patient antibodies to endomysial antigens

• Positive Result: Presence of IgG antibodies against endomysium indicates an autoimmune response, suggesting gluten sensitivity or celiac disease
• Negative Result: Absence of IgG antibodies against endomysium suggests a lower likelihood of gluten-related autoimmune conditions

• Quantitative Measurement: Results provide a quantitative measurement of IgG antibodies against endomysium, aiding in disease severity assessment
• Reported Titer: Positive results may include a reported titer, indicating the concentration of IgG antibodies present

Q: Is fasting required before taking the Endomysial Antibody IgG Test?
Fasting is usually not required. The test can be performed at any time, but specific instructions from healthcare providers should be followed
 

Q: How long does it take to get results from the test?
Results are typically available within a few days after the sample is collected
 

Q: Can this test diagnose celiac disease in all individuals?
While sensitive, the test may not be conclusive in individuals with IgA deficiency. Additional tests may be recommended in such cases
 

Q: Is the Endomysial Antibody IgG Test suitable for children?
Yes, the test can be used for children, especially in cases where celiac disease is suspected
 

Q: Can medications or other medical conditions affect test results?
Certain medications and medical conditions may influence results. It's crucial to inform healthcare providers about medications and health history
 

Q: How often should the test be repeated for monitoring gluten-free diet compliance?
The frequency of testing for monitoring purposes depends on individual health conditions and healthcare provider recommendations
 

Q: Can the test detect gluten sensitivity without celiac disease?
Yes, the Endomysial Antibody IgG Test can indicate gluten sensitivity even in the absence of full-blown celiac disease, offering valuable diagnostic information.